Inspire Medical Systems (INSP) EBIAT (2017 - 2025)
Inspire Medical Systems (INSP) has disclosed EBIAT for 9 consecutive years, with $136.1 million as the latest value for Q4 2025.
- Quarterly EBIAT rose 286.36% to $136.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $145.4 million through Dec 2025, up 171.77% year-over-year, with the annual reading at $145.4 million for FY2025, 171.77% up from the prior year.
- EBIAT hit $136.1 million in Q4 2025 for Inspire Medical Systems, up from $9.9 million in the prior quarter.
- In the past five years, EBIAT ranged from a high of $136.1 million in Q4 2025 to a low of -$16.8 million in Q3 2022.
- Historically, EBIAT has averaged $4.5 million across 5 years, with a median of -$6.1 million in 2023.
- Biggest five-year swings in EBIAT: surged 368.67% in 2023 and later plummeted 136.68% in 2025.
- Year by year, EBIAT stood at -$2.4 million in 2021, then surged by 231.74% to $3.2 million in 2022, then soared by 368.67% to $14.8 million in 2023, then soared by 138.6% to $35.2 million in 2024, then skyrocketed by 286.36% to $136.1 million in 2025.
- Business Quant data shows EBIAT for INSP at $136.1 million in Q4 2025, $9.9 million in Q3 2025, and -$3.6 million in Q2 2025.